Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 283 results for "ranbaxy industries"

Ranbaxy whistleblower Dinesh Thakur may set up patient advocacy group
Economic Times

Ranbaxy whistleblower Dinesh Thakur may set up patient advocac...

, who rattled the generic drug industry in India through his expose of malpractices in Ranbaxy as a whistleblower, may be looking to address issues related to the quality of pharmaceutical products in the country. He's considering plans to set up a patient ... Economic Times, 2 months ago

Sun Pharma gains after signing agreement with ICGEB to develop drug

Sun Pharmaceutical Industries rose 0.41% to Rs 801.65 at 14:25 IST on BSE after the company signed an agreement with International Centre for Genetic Engineering and Biotechnology to develop a novel botanical drug for treatment of dengue. The ...
 Capital Market12 hours ago Sun Pharma partners ICGEB to develop botanical drug for dengue [Mint, New Delhi]  Bloomberg9 hours ago Sun Pharma, ICGEB to develop botanical drug for dengue  Times of India15 hours ago Dengue-killer extract in climber leaf  Calcutta Telegraph58 minutes ago
India Infoline

Re-examine Sun Pharma MRs' transfer case, Bombay HC tells Industrial Court

MUMBAI: The Bombay High Court has directed an industrial court to re-examine charges of allegedly forced transfers of 54 medical representatives by drug maker Sun Pharmaceutical Industries. The industrial court had earlier this year dismissed an ...
 Economic Times1 day ago Eli Lilly to launch cancer drugs soon and other top pharma news of the day  India Infoline3 weeks ago Sun Pharma says sell-off plan of Irish plant final  Livemint.com3 weeks ago Mumbai Court rejects union’s claim against Sun Pharmaceutical Industries  Economic Times2 months ago


Reacting strongly against the ban on 344 FDC drugs, industry veterans call it a hasty decision and question the government's approval process which had earlier given the nod to these drugs. Edited excerpts of their insights By Usha Sharma FDC ban ...
 Financial Express5 days ago
The Hindu

Antihypertensive Drugs Market - Global Industry Analysis, Trends and Forecast 2015 - 2023

The growth of antihypertensive market is mainly driven by change in lifestyle, elevated stress level, and rise in prevalent population, early detection and penetration of combined dose. Human health is being affected by various factors which ...
 Press Release Ping1 day ago Scabies Treatment Market Global Industry Analysis, size, share and Forecast 2016-2026  MyNewsDesk1 week ago Growth Hormone Deficiency Treatment Market: Global Industry Analysis and Forecast 2016 - 2022  Digital Journal2 weeks ago Global Industry Analysis on Growth Hormone Deficiency Treatment Market, 2016 to 2022  Digital Journal3 weeks ago
Business Standard India

Sun Pharma makes Japan foray acquiring Novartis branded drugs

A man carrying a gas cylinder walks out of the research and development centre of Sun Pharmaceutical Industries in Mumbai. Photo: Reuters Sun Pharmaceuticals has announced acquisition of Novartis branded drug portfolio in Japan for $ 293 million ...
 Business Standard India1 month ago SUN PHARMACEUTICAL : Pharma acquires novartis brands in japan for $293 million  4 Traders1 month ago Sun Pharma acquires Novartis brands in Japan for $293 million  Hindu Business Line1 month ago Sun Pharma buys 14 of Novartis's brands in Japan for US$ 293 mn  India Brand Equity Foundation1 month ago

SC asks govt to reply on PIL seeking cancellation of Ranbaxy licence

The article below represents a preview only and is not meant for reuse or republishing. New Delhi, April 4 -- The Supreme Court on Monday asked the central government to reply in two weeks on a public interest litigation (PIL) seeking cancellation ...
 HT Syndication4 weeks ago

Evolving rules of insider trading: Are employees always insiders?

By Nikita Appaswami, Associate, Khaitan & Co and Aakash Choubey, Partner, Khaitan & Co The industry expected India's capital markets regulator's (Sebi) insider trading regulations of 2015 (New Regulations) to be highly progressive and solve ...
 Economic Times1 month ago Insider trading: Are employees always insiders?  Economic Times1 month ago

Expect 20% upside in Sun Pharma, says Pankaj Sharma

Pankaj Sharma, Head-Equities at Equirus Securities told CNBC-TV18, "We are bullish on Sun Pharmaceutical Industries . There is lot more visibility now whether there could be a resolution of this issue on Halol facility. We think this should be good ...
 Moneycontrol.com1 month ago

Bhupesh Bhandari: The rot in drug regulation

Dinesh Thakur, the whistleblower whose intervention led Ranbaxy to admit that it had falsified data while seeking the approval of the United States Food and Drug Administration, and pay penalty of $500 million to close the case, has taken the Indian ...
 Business Standard India1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less